P709-0241 Screening compound: N-[2-(1H-indol-3-yl)ethyl]-5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carboxamide

P709-0241 Screening compound: N-[2-(1H-indol-3-yl)ethyl]-5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carboxamide
P709-0241 Screening compound: N-[2-(1H-indol-3-yl)ethyl]-5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P709-0241
N-[2-(1H-indol-3-yl)ethyl]-5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P709-0241

Molecular Formula

C23H21N7O2 (C23 H21 N7 O2)

Compound Name

N-[2-(1H-indol-3-yl)ethyl]-5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carboxamide

IUPAC name

N-[2-(1H-indol-3-yl)ethyl]-5-methyl-1-[5-(3-methyl-124-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carboxamide

SMILES

Cc(n(-c(cc1)ncc1-c1nc(C)no1)nc1)c1C(NCCc1c[nH]c2c1cccc2)=O

InChI

InChI=1S/C23H21N7O2/c1-14-19(22(31)24-10-9-16-11-25-20-6-4-3-5-18(16)20)13-27-30(14)21-8-7-17(12-26-21)23-28-15(2)29-32-23/h3-8,11-13,25H,9-10H2,1-2H3,(H,24,31)

InChI Key

AYSWCUXENMFWEC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27613371

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

427.47

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.250

Distribution Coefficient, logD

3.248

Water Solubility, LogSw

-3.35

Polar Surface Area

88.320

Acid Dissociation Constant (pKa)

13.14

Base Dissociation Constant (pKb)

5.08

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

17.40

P709-0241 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Indole Derivatives (10091 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Proteases
  • GPCR
Structure:
  • Cyclic compounds
  • Mimetics
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P709-0241 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P709-0241?
Check Price and Availability of P709-0241, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P709-0241 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P709-0241
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P709-0241
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P709-0241 available by request